article · Open MIND
Background: Sickle cell disease (SCD) is a prevalent hemoglobinopathy in Morocco, with considerable clinical and biological variability, imposing a significant public health burden.Methods: A cross-sectional study analyzed 232 pediatric SCD patients in steady state (156 SS, 37 AS). Hematological and biochemical parameters were assessed to establish reference profiles for clinical evaluation and therapeutic follow-up.Results: The mean age was 8.4 years, with a male-to-female ratio of 1.4. Hemoglobin levels were significantly lower in SS compared to AS patients (6.45 vs. 9.3 g/dL; p < 0.001). Severe anemia affected 45.3% of patients, while normocytic, microcytic, and macrocytic anemia were observed in 33.2%, 18.5%, and 3.0%, respectively.Conclusions: Moroccan children with SCD, particularly SS patients, present marked hematological abnormalities reflecting severe disease. These findings highlight the importance of early diagnosis, systematic monitoring, and strengthened public health strategies to reduce morbidity and improve long-term outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.18695467
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.